C669-2588 Screening compound: N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}-4-methylbenzene-1-sulfonamide

C669-2588 Screening compound: N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}-4-methylbenzene-1-sulfonamide
C669-2588 Screening compound: N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}-4-methylbenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C669-2588
N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}-4-methylbenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C669-2588

Molecular Formula

C24H22N6O3S (C24 H22 N6 O3 S)

Compound Name

N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}-4-methylbenzene-1-sulfonamide

IUPAC name

N-{3-[(13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl)amino]quinoxalin-2-yl}-4-methylbenzene-1-sulfonamide

SMILES

Cc(cc1)ccc1S(Nc1nc2ccccc2nc1Nc(cc1)cc(N2C)c1N(C)C2=O)(=O)=O

InChI

InChI=1S/C24H22N6O3S/c1-15-8-11-17(12-9-15)34(32,33)28-23-22(26-18-6-4-5-7-19(18)27-23)25-16-10-13-20-21(14-16)30(3)24(31)29(20)2/h4-14H,1-3H3,(H,25,26)(H,27,28)

InChI Key

JTNXIFZZJAWXMY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD07157287

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

474.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.435

Distribution Coefficient, logD

3.290

Water Solubility, LogSw

-4.35

Polar Surface Area

85.698

Acid Dissociation Constant (pKa)

6.29

Base Dissociation Constant (pKb)

4.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

C669-2588 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

C-Met Library (15277 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C669-2588 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C669-2588?
Check Price and Availability of C669-2588, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C669-2588 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C669-2588
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C669-2588
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C669-2588 available by request